Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss)

v3.5.0.2
Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Sales $ 18,283 $ 0 $ 182,474 $ 0
Cost of Sales 12,019 0 70,894 0
Gross Margin 6,264 0 111,580 0
Operating expenses        
Sales and marketing 187,265 0 269,463 0
Research and development 813,773 768,301 1,231,563 1,378,123
General and administrative 577,853 372,342 1,881,467 874,443
Share-based compensation expense (Notes 9(v) and 10) 204,842 26,724 424,090 1,324,282
Depreciation (Note 6) 23,590 15,478 33,753 32,480
Total operating expenses 1,807,323 1,182,845 3,840,336 3,609,328
Other expenses (income)        
Interest expense (Note 7) (5,203) 0 10,031 0
Other income (395,296) (5,533) (406,514) (23,012)
Change in fair value of warrant derivative liability (Note 11) (2,130,106) (3,496,070) (1,739,047) (4,413,819)
Total other expenses (income) (2,530,605) (3,501,603) (2,135,530) (4,436,831)
Net income (loss) and comprehensive income (loss) for the period $ 729,546 $ 2,318,758 $ (1,593,226) $ 827,503
Income (loss) per share - basic $ 0.01 $ 0.03 $ (0.02) $ 0.01
Income (loss) per share - diluted $ 0.01 $ 0.02 $ (0.02) $ 0.01
Weighted average number of shares outstanding - basic 85,924,462 72,408,313 87,232,426 61,491,674
Weighted average number of shares outstanding - diluted 89,789,461 76,270,355 87,232,426 70,064,316